The current status of anti-GPCR drugs against different cancers

• Главные авторы: Sana Usman (Автор), Maria Khawer (Автор), Shazia Rafique (Автор), Zara Naz (Автор), Komal Saleem (Автор)
• Формат: ‌
• Опубликовано: Elsevier, 2020-12-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

G protein coupled receptors (GPCRs) have emerged as the most potential target for a number of drug discovery programs ranging from control of blood pressure, diabetes, cure for genetic diseases to treatment of cancer. A panel of different ligands including hormones, peptides, ions and small molecule...